Skip to content

Three Quick Facts: Computacenter, Prudential, Abingdon Health


Three things you need to know in the financial markets today from investment writer, Tony Cross.

#1. Computacenter: another bumper set of results, tough comparatives ahead

Full year numbers from Computacenter LON:CCC grossed invoiced income breaking above the £10bn mark, accompanied by a 44bps margin improvement and a 10% increase in gross profits. Whilst further progress is expected in the current FY, management note that this will be weighted into the second half and will come against some tough comparatives.

#2. Pru’s FY numbers impress despite macro backdrop and China challenges

Full year numbers from Prudential LON:PRU are out today with management heralding a very strong set of results despite the challenging macroeconomic environment. The adjusted operating profit is up 8% and total dividends of 20.47c have been declared for the year, up 9%.

As is the case with insurers the report is a lengthy read, but concerns that the performance in China would be sluggish can arguably be offset by the fact gross premiums only fell moderately and now account for 49% of the group’s figure, up from 47% a year ago.

#3. First Abingdon LFTs to be sold under Boots brand

AIM listed Abingdon Health LON:ABDX has this morning announced that Boots will now stock the company’s lateral flow tests under the pharmacy’s label. The first two products will test for Iron and Vitamin D deficiency, reflecting the increased consumer confidence in and adoption of at-home testing.

Looking for great investing ideas? Sign up to our free newsletter.

Join us on WhatsApp

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

CME Group
FP Markets
Back To Top